Literature DB >> 474195

Resolution of renal amyloidosis secondary to rheumatoid arthritis.

H M Falck, T Törnroth, B Skrifvars, O Wegelius.   

Abstract

A patient with seronegative rheumatoid arthritis developed a nephrotic syndrome. Histological examination of renal biopsy disclosed moderate amyloidosis. Ultrastructurally the glomerular amyloid deposits were seen to be located both within the mesangium and subepithelially in the peripheral capillaries. The patient was treated with prednisone and cyclophosphamide for two years. The nephrotic syndrome remitted and a follow-up biopsy showed almost total disappearance of Congo red positive amyloid substance. Electron microscopy showed abundant finely granular material but only small amounts of fibrillar amyloid in the mesangial regions and intramembranous lucent areas containing few amyloid fibrils but no subepithelial deposits in the peripheral capillaries. We conclude that the mesangial amyloid substance was degraded to granular material and that the subepithelial amyloid deposits were resolved by mechanisms similar to those involved in the resolution of subepithelial immune complex deposits, i.e. through slow washing out and incorporation into the basement membrane.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 474195     DOI: 10.1111/j.0954-6820.1979.tb06121.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  7 in total

1.  Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease.

Authors:  K Berglund; C Keller; H Thysell
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

2.  Grand rounds--Hammersmith Hospital. Reactive (AA) systemic amyloidosis. A cause of refractory nephrotic syndrome.

Authors: 
Journal:  BMJ       Date:  1996-04-27

3.  Xanthogranulomatous pyelonephritis and amyloidosis.

Authors:  N Tümer; F Yalçinkaya; M Ekim
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

4.  Renal amyloidosis in juvenile chronic arthritis: evolution after chlorambucil treatment.

Authors:  G Deschênes; A M Prieur; F Hayem; M Broyer; M C Gubler
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

5.  Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.

Authors:  Tadashi Nakamura; Yuji Yamamura; Kunihiko Tomoda; Michishi Tsukano; Masahiro Shono; Satoshi Baba
Journal:  Clin Rheumatol       Date:  2003-11-07       Impact factor: 2.980

6.  Colchicine induced remission in amyloid nephrotic syndrome.

Authors:  R Oren; G Pizov; Y Naparstek; A Rubinow
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

7.  Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis.

Authors:  Masaru Matsui; Satoshi Okayama; Hideo Tsushima; Kenichi Samejima; Tomoko Kanki; Ayako Hasegawa; Katsuhiko Morimoto; Yasuhiro Akai; Masato Takano; Shiro Uemura; Chiho Ohbayashi; Yoshihiko Saito
Journal:  Case Rep Nephrol       Date:  2014-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.